Skip to main content

FINDELL CAPITAL MANAGEMENT LLC

Position in LQDA — Liquidia Corp

CIK 1814465 New York, NY

Position in LQDA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$132,169,706
+$33,823,230 QoQ
Shares Held
3,502,112
+22.8% QoQ
Ownership
3.94%
of shares outstanding
% of Portfolio
38.93%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Derivatives in LQDA

reported options exposure · as of Mar 31, 2026
CallValue
$1,887,000
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

FINDELL CAPITAL MANAGEMENT LLC holds $132,169,706 across 1 Drug Manufacturers - Specialty & Generic name. LQDA ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LQDA
Liquidia Corp
This page
3,502,112 $132,169,706

All Filings in LQDA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $132,169,706 3,502,112
2026-03-31 $1,887,000 50,000
2025-12-31 $41,388,000 1,200,000
2025-12-31 $5,380,440 156,000
2025-12-31 $98,346,476 2,851,449
2025-09-30 $34,341,948 1,510,200
2025-09-30 $64,354,200 2,830,000
2025-06-30 $1,246,000 100,000
2025-06-30 $37,380,000 3,000,000
2025-03-31 $42,627,500 2,890,000
2024-12-31 $36,220,800 3,080,000
2024-09-30 $31,935,390 3,193,539
2024-06-30 $28,800,000 2,400,000
2024-06-30 $4,800,000 400,000
2024-03-31 $31,048,750 2,105,000
2023-12-31 $25,094,580 2,086,000